Announcements Trials

Browse Landscape

Phase

Status

Recruiting 8 Active not recruiting 6 Not yet recruiting 5 Completed 5 Terminated 3 Unknown 2 Withdrawn 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 40 Cisplatin 37 Pemetrexed 33 Radiotherapy 23 Paclitaxel 22 pembrolizumab 20 durvalumab 19 Docetaxel 19 Gemcitabine 18 Nivolumab 15 Radiosurgery 14 Etoposide 13 atezolizumab 11 Erlotinib Hydrochloride 11 Taxes 8 Magnetic Resonance Spectroscopy 8 Drug Therapy 8 Bevacizumab 8 Cyclophosphamide 7 Platinum 6 Gefitinib 6 Surveys and Questionnaires 5 Biopsy 5 130-nm albumin-bound paclitaxel 5 1,2-diaminocyclohexaneplatinum II citrate 5 sotorasib 4 Ramucirumab 4 Radiation 4 Immunotherapy 4 Fluorodeoxyglucose F18 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Observation × Thoracic × Clear all

NCT03770299 2022-03-24

CheckMate 9TN

Bristol-Myers Squibb

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡